Pronto Plus
NDC Package 63736-240-24
Package Information
Pronto Plus is read package insert carefully before using. Marketed by Insight Pharmaceuticals Llc, this product is identified by NDC 63736-240 and is authorized under FDA application part357B.
Identification & Billing
- RxCUI: 1050119 - Pronto Plus Pinworm 360 MG in 2.5 mL Oral Suspension
- RxCUI: 1050119 - pyrantel pamoate 144 MG/ML Oral Suspension [Pronto Plus Pinworm]
- RxCUI: 1050119 - Pronto Plus Pinworm 144 MG/ML (pyrantel base 50 MG/ML) Oral Suspension
- RxCUI: 1050119 - Pronto Plus Pinworm 360 MG per 2.5 ML (pyrantel base 125 MG per 2.5 ML) Oral Suspension
- RxCUI: 199106 - pyrantel pamoate 144 MG in 1 mL Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63736 - Insight Pharmaceuticals Llc
- 63736-240 - Pronto Plus
- 63736-240-24 - 24 CARTON in 1 CASE / 1 BOTTLE in 1 CARTON / 59 mL in 1 BOTTLE
- 63736-240 - Pronto Plus
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63736-240-24 identifies a specific commercial package of 24 carton in 1 case / 1 bottle in 1 carton / 59 ml in 1 bottle of Pronto Plus Pinworm Treatment, labeled by Insight Pharmaceuticals Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Insight Pharmaceuticals Llc on September 20, 2010. The current certification is valid through December 31, 2017.
How is this Insight Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63736024024. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.